Search

You searched for "invasive"

336 results found

Molecular biology – bladder cancer

1 January 2014 | | Basic Science Research, Urologic Oncology
Background Bladder cancer is the most common cancer of the urinary tract and approximately 90% of bladder cancers diagnosed in North America and Europe are transitional cell carcinomas (TCC). For the purposes of diagnosis and treatment, bladder cancer is often...

ABU joins BCG in fight against NMIBC recurrence?

1 May 2017 | | Urologic Oncology
The authors test a hypothesis retrospectively in two cohorts of patients with non-muscle invasive bladder cancer (NMIBC), that endogenous bacteria in the bladder might exert antitumour effects, similar to live mycobacteria (BCG), through local immune-related or other mechanisms, on NMIBC...

Comparing intravesical chemohyperthermia with Mitomycin C versus BCG in treating bladder cancer

1 July 2016 | | Urologic Oncology | BCG, Device-assisted therapy, Hyperthermia, Intravesical chemotherapy, Mitomycin-C, Non–muscle-invasive bladder cancer, Radiofrequency, Randomised controlled trial, Recurrence rate, Thermochemotherapy
In the advent of the recent Bacillus Calmette–Guérin (BCG) crisis, the importance of alternative adjuvant treatments for intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) has been highlighted. Chemohyperthermia (CHT) has emerged as an option, however there remains a lack of...

BCG maintenance therapy not superior to induction alone

1 July 2015 | | Urologic Oncology | Bacillus Calmette-Guérin, Bladder cancer, Maintenance therapy
With the ongoing shortage of BCG remaining an issue for urologists in the UK and further afield, this topical paper presented the results of the CUETO study evaluating the outcome of a modified three-year BCG maintenance regimen versus induction therapy...

Uropathology: what’s the diagnosis?

1 September 2017 | Basic Science Research, Urologic Oncology
Case 1 A 28-year-old man presented with a left testicular mass. Tumour markers were taken and he went on to have a radical inguinal orchidectomy. The specimen and histology are shown. Which testicular tumour markers were taken? What does their...
The BMJ cover image

COVID-19 and acute kidney injury

7 July 2020 | | Trauma and Emergency Urology, COVID-19 - Urology News
Newspapers and online media are full of the effects of the coronavirus on airways and olfactory functions and the importance of respiratory physicians (pulmonologists in the USA), ventilators and intensive care teams. However, as per the Intensive Care National Audit...

PTNS in overactive bladder

1 January 2014 | | Functional Urology
This article will be of interest to those who undertake percutaneous tibial nerve stimulation (PTNS) or are planning to start doing so. This is a computer aided search between 2000-2011 to identify randomised controlled trials (RCT), controlled clinical trials (CCT)...
Editor's Choice journal image EAU

Prostate cancer and an electronic nose

7 January 2020 | | Urologic Oncology
So far the transrectal ultrasound guided (TRUS) biopsy has been the ‘gold standard’ for diagnosing prostate cancer. However, it is invasive and can lead to complications, so there is a need for new non-invasive diagnostic tools to avoid unnecessary biopsy...

Recent developments in bladder cancer – NMIBC

3 May 2022 | | Urologic Oncology
Every year, roughly 10,300 individuals are diagnosed with bladder cancer in the UK, making it the 11th most common cancer in the UK, and the eighth most common cancer in men [1]. Of those diagnosed with the disease, 75-85% will...

Peno-scrotal extramammary Paget’s disease

1 July 2015 | | Infection
Epidemiology Extramammary Paget’s disease (EMP) is a rare intraepithelial neoplasm, which is rarely invasive and has an incidence of six per million person-years as calculated by a European SEER analysis [1]. It usually affects apocrine gland-bearing areas, especially the vulvar,...

Bladder carcinoma MRI

1 September 2018 | | Urologic Oncology, Uroradiology
Bladder malignancy is one of the commonest malignancies of the renal tract, accounting for approximately 6% of male malignancy and 2% of female malignancy. The incidence increases with patient age with 70% of patients being over the age of 65...

Richard Wolf Range Update

10 January 2020
Richard Wolf a global business with headquarters in Germany and over a century of tradition and expertise in the field of endoscopy. We develop, manufacture and market specific system solutions for minimally invasive human medicine.